Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Post by JensLenson May 31, 2022 9:49am
88 Views
Post# 34719687

Multiple Sclerosis Drugs Market Size , FSD has a MS drug

Multiple Sclerosis Drugs Market Size , FSD has a MS drug

Multiple Sclerosis Drugs Market Size & Trends 2022 - 2028 [CAGR 3.9%] | Industry Share, Growth by Fortune Business Insights

According to Fortune Business Insights, the global Multiple Sclerosis Drugs Market size is projected to reach USD 33.17 billion in 2029, at CAGR of 3.9% during forecast period; Increasing R&D in Neurology to Boost Market Growth: Fortune Business InsightsTM


Multiple Sclerosis Drugs Market Size & Trends 2022 - 2028 (globenewswire.com)
<< Previous
Bullboard Posts
Next >>